Regenosome and Skypharma Join Forces for Innovative Longevity Research Regenosome and Skypharma have established a joint research agreement to explore innovative treatments for age-related and neurodegenerative diseases using low-molecular-weight compounds.

Regenosome and Skypharma Join Forces for Innovative Longevity Research #Japan #Tokyo #Regenosome #Skypharma #JointResearch